Sunday, May 11, 2008

Bayhill Therapeutics Announces Presentation of MS Drug Candidate ...

Bayhill Therapeutics Announces Presentation of MS Drug Candidate ...
InfoBolsa - Spain
Garren s podium presentation will discuss Bayhill s lead product candidate BHT-3009 in relation to an abstract (#857) entitled "Results from a Phase 2 Trial ...
See all stories on this topic

tysabri

Biogen tells shareholders to nix Icahn's board bids
Bizjournals.com - Charlotte,NC,USA
The company's products include Avonex and Tysabri for certain cases of multiple sclerosis and Rituxan for a type of non-Hodgkin's lymphoma, a cancer of the ...
See all stories on this topic

PDL BioPharma Q1 net loss widens
RTT News - Williamsville,NY,USA
Royalty revenues for the first quarter roe to $50.0 million from $48.6 million a year ago, driven mainly by higher royalties earned on sales of Tysabri and ...
See all stories on this topic

PDL BioPharma Reports First Quarter 2008 Financial Results
CNNMoney.com - USA
... an increase driven primarily by higher royalties earned on sales of Tysabri® and Synagis®, partially offset by a decrease in royalties received from ...
See all stories on this topic


Good News: Adult Stem Cells Offer Relief from Multiple Sclerosis
CitizenLink - Colorado Springs,CO,USA
A surprise breakthrough in adult stem-cell research means some people with multiple sclerosis are finding relief. Researchers at the University of Ottawa ...
See all stories on this topic

Health & Medicine
Investor's Business Daily (subscription) - USA
Next would come treatments for autoimmune diseases, among them multiple sclerosis, lupus, rheumatoid arthritis and diabetes. Meanwhile, stem cell treatment ...
See all stories on this topic

A surprise breakthrough in adult stem-cell research means some ...
CitizenLink - Colorado Springs,CO,USA
“It’s about time, frankly, that people woke up to the fact that adult stem cells are the ones that hold real promise to treat patients.”
See all stories on this topic


Canada orders vitamin D study
Globe and Mail - Canada
Health Canada says it will launch a study by this fall investigating dramatic claims that a lack of vitamin D could be linked to ailments such as cancer, ...
See all stories on this topic

Globe: We've Got It Down to a Fine Science (Toronto Biomed/tech ...
By AlvinofDiaspar
Tom Hudson, a renowned genome scientist, moved here two years ago from Montreal to head the newly established Ontario Institute for Cancer Research. Biochemist Aled Edwards, who directs the Clinical Genomics Centre, relocated from ...
Urban Toronto Forum - http://www.urbantoronto.ca

Catholic church slated on eve of embyro vote
Times Online - UK
... be used to produce stem cells that could be used for research into illnesses such as Parkinson’s disease, multiple sclerosis and motor neurone disease. ...
See all stories on this topic

Cedar Funding investors talk
Monterey County Herald - Monterey,CA,USA
A former interior designer, Abraham-North has multiple sclerosis, which forced her to quit working 15 years ago. Her divorce set her back financially, ...
See all stories on this topic

Magnet Lab Researchers Make Observing Cell Functions Easier
Now that the genome (DNA) of humans and many other organisms have been sequenced, biologists are turning their attention to discovering how the many thousands of structural and control genes -- the "worker bees" of living cells that can turn genes on and off -- function.

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home